VITALITY Study Results Announced: Immunotherapy Shows Great Promise as a Neoadjuvant Treatment Before Liver Transplantation in Liver Cancer
Editor's Note: Immune checkpoint inhibitors (ICI) are gradually becoming a key therapeutic strategy in the neoadjuvant treatment of advanced hepatocellular carcinoma (HCC). Their widespread application reflects the deep understanding and…